Sign inJoin waitlistJoin the waitlist

Melissa Yacur

Program Director · Inova Fairfax Hospital Campus

Credentials: · · · · · · ·

History

Inova Fairfax Hospital Campus
Present

Hematology and Medical Oncology
University of Virginia School of Medicine
2018–2021
Internal Medicine
Penn State Milton S Hershey Medical Center
2015–2018
Temple University School of Medicine
2011–2015

Research

Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients
Annals of Oncology · 2017 · 192 citations
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
Haematologica · 2018 · 149 citations
Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers
Cancer Discovery · 2013 · 101 citations

Alan Skarbnik
2 papers
Allison Winter
2 papers · 2 as a resident
Andre Goy
2 papers
Anthony Mato
2 papers
Brian Hill
2 papers
BC
Bruce Cheson
2 papers
CN
Chadi Nabhan
2 papers
Chaitra Ujjani
2 papers
Clive Zent
2 papers
Danielle Brander
2 papers
Jakub Svoboda
2 papers
JP
Jeffrey Pu
2 papers

Clinical trials

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Site PI · Recruiting
Natera, Inc.
2026–2037
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Site PI · Recruiting · Phase 3
Stemline Therapeutics, Inc.
2024–2032
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2033